Cyber security of elections
This briefing discusses cyber security risks to elections. It explores the potential impacts on election outcomes and how these risks can be tackled.
Psychedelic-assisted therapy in the treatment of addiction
Researchers are exploring the role of psychedelic drugs as a treatment for addictions. How are addiction disorders currently treated and what does the latest research on psychedelic drugs show?
How is artificial intelligence affecting society?
What are the effects of AI for decision making, workplace rights, transparency, surveillance, civil liberties and intellectual property?
-
Rapid response
General election polling in the UK
What are the challenges of public opinion polling in advance of a general election? Who regulates it, and does it have an impact on the public?
-
Rapid response
Psychedelic drugs to treat eating disorders
Researchers are exploring the role of psychedelic drugs as a treatment for eating disorders. How are eating disorders currently treated and what does the latest research on psychedelic drugs show?
-
Rapid response
Psychedelic drugs to treat post-traumatic stress disorder (PTSD)
How is PTSD treated, how successful are current treatments and what is the potential role for psychedelic-assisted therapy?
-
Rapid response
Election turnout: Why do some people not vote?
The number of people voting in elections is an indicator of democratic health. In UK general elections, this number has declined since 1997. Why is this? What could be done to increase turnout?
-
Rapid response
Psychedelic-assisted therapy to treat anxiety disorders
How are anxiety disorders treated, how successful are current treatments and what is the potential role for psychedelic-assisted therapy?
-
Rapid response
Psychedelic drugs to treat depression
Researchers are exploring the science of psychedelic drugs as a potential treatment for depression. How effective could they be, and what are the regulatory and legal challenges in their use?
-
Rapid response
Human challenge studies in the study of infectious diseases
What can deliberately infecting healthy people tell us about infectious diseases? How is this useful for developing treatments, and how do we manage the risks?
-
Rapid response
Immunity to Covid-19: March 2023 update
How do our bodies defend against Covid-19? Read how immune responses differ across people, variants, reinfection, vaccination, and current immunisation strategies.
-
Rapid response
Science Diplomacy
A overview of science diplomacy, outlining its role in scientific collaborations and to support international diplomatic relationships, and a resume of recent developments.
-
Rapid response
Drug Therapies for COVID-19
Research studies involving thousands of people have allowed scientists to test which drugs are effective at treating COVID-19. Several drug therapies are now available to treat people who are in hospital with COVID-19, or to prevent infections in vulnerable people becoming more serious. This briefing explains which drugs are available, the groups of people in which they are used and how they work. It also outlines the importance of monitoring the emergence of new variants and drug resistance.
-
Rapid response
The future of COVID-19 vaccines
A new generation of COVID-19 vaccines could support vaccination strategies in the long term. But what are the latest developments from preclinical and clinical trials?
-
Rapid response
COVID-19: Omicron, recent developments, and the likely impact of future variants on the pandemic
The Omicron variant of the SARS-CoV-2 virus, which causes COVID-19, has been found across the world since it was first detected in early November 2021. This article describes the characteristics of the variant and its health impacts. It also discusses vaccine effectiveness against the variant and the medium and long-term outlook for the future course of the pandemic.
Total results (page 1 of 6)